AiMIFY™, developed through the collaboration between Bracco Imaging and Subtle Medical, represents a breakthrough in AI-powered medical imaging. The software uses advanced deep learning algorithms to enhance contrast in brain MRI scans—achieving up to double the visual contrast typically produced by standard gadolinium-based contrast agents (GBCAs). This innovation enables radiologists to detect subtle abnormalities, such as small or poorly enhanced lesions, without requiring changes to imaging protocols or additional contrast dosage, making it a seamless upgrade to existing diagnostic workflows.

In clinical practice, AiMIFY™ is designed to integrate effortlessly into MRI systems, providing enhanced image clarity in real time. Its broad compatibility across scanner vendors, imaging sequences, and patient types ensures widespread utility and consistent performance. This added layer of diagnostic precision is especially valuable in early disease detection and complex neurological assessments, helping physicians make faster, more confident decisions while minimizing patient risk from excessive contrast use.